Form 8-K · Current report
Linde plc 8-K, filed Oct 29, 2026
- Filed
- CIK
- 0001707925
- Accession no.
- 0001654954-26-009199
Summary
Linde plc reported third-quarter 2026 sales of $9.4 billion, up 9% year over year, and adjusted diluted EPS of $4.59, up 9%, while GAAP net income fell 12% to $1,692 million and diluted EPS fell 11% to $3.66. The company guided full-year 2026 adjusted EPS to $17.82–$17.92, representing 8%–9% growth, with fourth-quarter adjusted EPS of $4.40–$4.50, and CEO Sanjiv Lamba said customer proposal activity remained robust, particularly in electronics.
Key points
- Third-quarter adjusted operating profit was $2,763 million, up 8%, at a 29.4% adjusted margin; reported operating profit was $2,150 million.
- Operating cash flow was $3,169 million and free cash flow $1,777 million after $1,392 million of capital expenditures; $1,685 million was returned to shareholders net of issuances.
- Underlying sales rose 5% on 3% price attainment and 2% volumes, led by the electronics, chemicals & energy, and manufacturing end markets.
- The project backlog was $11 billion and full-year 2026 capital expenditures were guided to $5.5–$6.0 billion.
Written by an AI model from the filing text. It can be incomplete or wrong; the filing on SEC.gov is the record.
Items reported
- 2.02Results of Operations and Financial Condition
- 9.01Financial Statements and Exhibits
From the filing
ITEM 2.02 Results of Operations and Financial Condition On October 29, 2026, Linde plc (the “Company”) issued a press release setting forth Linde plc’s results of operations for the quarter ended September 30, 2026. A copy of Linde plc’s press release is furnished herewith as Exhibit 99.1 and is hereby incorporated by reference in this Item 2.02. ITEM 9.01. Financial Statements and Exhibits. (d) Exhibits. The following exhibit is furnished herewith pursuant to Item 2.02 hereof: Exhibit No. …
An excerpt of the text as filed with the SEC, cut for length.
Readster writes AI-generated summaries of public filings for research purposes only. Summaries can be incomplete or wrong — check the original filing on SEC.gov before relying on it. Nothing here is investment, legal or medical advice.